[1]
Berden, F.A., van Zwietering, I.M., Maan, R., de Knegt, R.J., Kievit, W. and Drenth, J.P. 2016. High Risk of Infection During Triple Therapy with First- Generation Protease Inhibitors: A Nationwide Cohort Study. Journal of Gastrointestinal and Liver Diseases. 25, 2 (Jun. 2016), 197–204. DOI:https://doi.org/10.15403/jgld.2014.1121.252.th3.